Summary. Strains of Aspergillus flarus, Fusariuni sp., Rhiropus sp. and Candida albicans all produced inhibitors of P-adrenergic receptor binding; strains of Saccharoniyces sp. and Sc.hizo.str~~charonz?.ces sp. did not. In tests with glutamic acid as the sole nutrient source, a Fusuriim sp. produced four-fold larger amounts of inhibitor than the other fungi. The inhibitor from the Fusarium sp. was further purified by lyophilisation and sequential solvent extraction in chloroform, ethyl acetate and butanoi; 60% of the original activity was recovered. The inhibitor had an estimated molecular size of 650 Da, and did not absorb light in the iisible or ultraviolet range. When compared with a similar inhibitor from Escherichia d i . the Fzrsuriunz sp. inhibitor appeared to be a more potent inhibitor of P-adrenergic and dopaminergic binding to mammalian cells.
Introduction
Micro-organisms, including yeast and fungi, are capable of interacting with various mammalian hormone systems. For example. Aspergillus alliacerts produces a struct urally-related antagonist of cholecyst o k i n in , Trichli oplz?q ton meii t u y r ophj 1 t es has pro t ei n s that bind progesterone,2 Pciracoccidioides brasilietisis has proteins that bind-estradiol," and Succharonr?ws ccwrisiw may produce an oestrogen-like substance.J The production of extracellular inhibitors of the 8-adrenergic response by bacteria and fungi in mammalian cells is of particular interest." We have noted previously that certain bacteria produce a substance that can inhibit the binding and function of adrenergic receptor systems, and we made preliminary observations that certain fungi also produce an inhibitor ofgadrenergic binding.' l o This report extends these preliminary observations to include representatives of the major groups, and the inhibitor from a Fusariunr sp. was further purified and characterised. stored at 4"C, and passaged monthly. Escherichia coli strain 9637 was from a local collection.
Materials and methods

Preparation of cuIture.filtrates
Overnight standing cultures of bacteria or yeast were grown in 50 ml of trypticase soy broth at 37°C. After centrifugation at 9000 q for 10 min, cells were resuspended in nutrient solutions containing either glucose or glutamic acid, 1 mg/ml in phosphatebuffered saline (PBS) and agitated overnight at 37"C, Supernates were passed through 0.45-pm filters and collected. Filamentous fungi were incubated in 50 ml of Sabouraud's maltose broth at room temperature until mycelial mats formed (generally 5-7 days). After washing three times with 50ml of PBS, the culture media were replaced with 50 ml of nutrient solution, glucose or glutamic acid 1 mg/ml in PBS, followed by incubation for various periods (1-7 days) at room temperature. Replacement media were collected, filtered through cotton gauze, and subjected to further centrifugation and filtration.
A dr ene r y ic h in ding assaj3s C6 rat glial or Y1 mouse adrenal tissue-cultured cells for assay were maintained in F10 medium." The standard reaction mixture contained, in a final volume of 1 ml, 10"-10' tissue-cultured cells, 0.1 pCi ((4. 100000 cpm) of 1 x M 3H-dihydroalprenolol (for P-adrenergic binding) or 0.1 yCi (c. 100000 cpm) of 5 x 1 0 -'~ 3H-spiperone (for dopaniinergic binding) in 5 0~1 , with or without test solutions or unlabelled ligand." After incubation at 37°C for 10 min, the cells were collected by filtration; the filters were washed three times with PBS before being dried and placed in scintillation fluid, and the number of filter-bound counts was determined in a p-scintillation counter. These reaction mixtures and incubation times ensured optimal binding (i.e. steady state) conditions.ll The percentage of the total available counts that were specifically bound (Bsp) was used for probit analysis to calculate the volume required for 50 O/O inhibition (Ij0).l2 Bsp (i.e. specific binding) is the difference between total bound counts and non-specific counts, and is expressed as a percentage of the total available counts. Non-specific counts are the counts obtained in the presence of excess (1000-fold) unlabelled ligand, i.e., L-alprenolol (for P-adrenergic binding), or haloperidol (for dopaminergic binding). Experiments were repeated at least three times, with triplicate determinations of binding within each experiment. Student's ttest was used for statistical analysis.
Purification of inhibitor
Filtrates of supernates of Fusarium sp. incubated for 5 days with glutamic acid 1 mg/ml were harvested and concentrated by lyophilisation. Identical volumes of uninoculated medium were prepared in the same way as controls for all procedures. No inhibitory activity was lost after lyophilisation. After reconstituting the lyophilised material in deionised distilled water to an 1 00-fold increase in concentration, sequential solvent extractions were performed with chloroform, ethyl acetate and butan01.l~ Solvent extracts of culture filtrates and control solutions were evaporated to dryness in a heating block. When equal samples of extracts and residues of controls and culture filtrates were examined for P-adrenergic binding inhibition, no activity was found in either chloroform or ethyl acetate extracts. All of the inhibitor activity was found in the butanol extracts and unextracted residue. Butanolextracted inhibitor was then subjected to dialysis with Type C 0.5 tubing (Spectrum Medical Industries Inc., Los Angeles, CA, USA), which has a mol. wt exclusion of 500. Extract reconstituted in 5 ml of deionised distilled water was dialysed at 5°C against 2 L of deionised distilled water, changed daily on three successive days. After dialysis, 60% of the original activity was recovered. This scheme of purification is shown in fig. 1 . A further attempt at purification of the Fusarium sp. inhibitor was made with Sephadex G-50 gel filtration. This eliminated much, but not all of the highly pigmented material. Butanol-extracted inhibitor was also dried, reconstituted with methanol to the original volume, and subjected to separation by thinlayer chromatography. A solvent system of methanol : water (9.1, v: v) was used on K2 cellulose plates (250-pm thickness, without binder, Whatman Paper Ltd). Sections (1 cm2) were scraped from the plate covering zones outside the point of sample application as well as areas covering regions from the point of application to the solvent front. Cellulose scrapings were then resuspended in the solvent, mixed and subjected to centrifugation (3000 rpm for 3 min) in an Eppendorf micro-centrifuge. Supernates were dried in a heat block, and the residues were assayed for P-adrenergic binding inhibition activity.
Results
Production of inhibitors by Jilamentous fungi and yeasts
A.Javus and the Fusarium sp. produced the greatest amount of inhibitors/volume of replacement nutrient 
Nrrtrivnt requirvriients for procluctioil of inhibitor
Various biochemical intermediates and products were tested as sources of replacement nutrients for the formation of [kdrenergic inhibitor by A . ,flaws and Fitsaritun sp. Both Fusarium sp. and A.fluvus produced inhibitor from sodium citrate and sodium succinate, but Fusariurn sp. produced four times as much as A . .Parus from glutamic acid. As similar studies with E. coli showed that glutamic acid was a favourable substrate for the formation of inhibitor by b a~t e r i a ,~ and as this substrate was more suitable for future attempts to purify inhibitors, most investigations were conducted with glutamic acid as the substrate.
Characterisation of inhibitor
When subjected to thin-layer chromatography, inhibitor was located in a homogeneous area with a peak R, value of 0.6. Material recovered from this region was found not to absorb light in either the visible or ultraviolet ranges.
An attempt to define the molecular size of the inhibitor by gel filtration with Sephadex G-10 is shown in fig. 3 . According to this method, the estimated molecular size of the fungal inhibitor is 650 Da similar to that noted for the bacterial inhibitomH
Comparison of fungal und bacterial inhibitors
Inhibitors from Fusarium sp. and E. coti produced with glutamic acid as substrate were compared for inhibition of /3-adrenergic and dopaminergic binding in Y 1 and C6 cells (table IT). These results indicate that the fungal inhibitor activity is greater than that of E. coli, and that both P-adrenergic and dopaminergic binding appear to be affected to similar degrees by each inhibitor. ...
(034)
...
(0.04)
(0.40)
... * Volumes tested over four-fold dilution range; p = < 0.05.
Discussion
Several fungi produce inhibitors of P-adrenergic and dopaminergic binding. The inhibition is similar to that previously observed with bacteria,8* although the fungal inhibitor may be more potent than that produced by bacteria. However, further purification and standardisation of the inhibitors will be needed to validate these preliminary conclusions. Fungi produce the inhibitor when incubated with glucose alone, and maximal levels appear after 3-5 days. Inhibitor is also synthesised when succinic acid or the amino acids isoleucine or glutamic acid are used as substrate.
Among the fungi and yeasts tested, Fusarium sp. and A.Jlavus produced the highest levels of inhibitor. The mechanisms of induction and control of inhibitor production remain to be defined. Loss of Fusarium sp. inhibitor activity was observed when extracts were treated with some ion-exchange resins, silica gel, and cellulose-containing binders (unpublished observations). Inhibitor activity was recoverable after thinlayer chromatography on cellulose plates. The fungal inhibitor was found in butanol extracts by a procedure applied to the isolation of toxic substances produced by Fusarium sp.13 The loss of some inhibitor activity by dialysis may have been due to the loss of a co-factor or of inhibitor molecules. Fusarium sp. produce substances that chelate divalent cations and are particularly difficult to isolate by routine ~r0cedures.l~ The inhibitor contains no amino acids, nucleic acids, or other substances capable of absorption of light in the ultraviolet and visible ranges tested. The inability to use many routine procedures for isolation and purification, coupled with the presence of the inhibitor in small amounts, have hampered further purification.
Since there is no information about charges or diffusion of the inhibitor, there is limited accuracy in mol. wt estimation by gel exclusion chromatography with Sephadex G10;15 the inhibitor appeared to elute with a molecular size of c. 650 Da.
P-Adrenergic and dopaminergic receptor binding were both inhibited by products of Fusarium sp. and E. coli when tested in C6 and Y1 cells. Activation of adenylate cyclase secondary to j3-adrenergic hormone binding occurs in C6 cells, but not in Y1 cells.ll If binding had been inhibited in only one cell type, it could be possible that bacteria or fungal products, or both, affect the internal cell mechanisms first, and that such an alteration would then modify the external binding site as a secondary effect. Since this is not the case, it is likely that the inhibitor blocks binding directly. Binding of other ligands (e.g., cholera toxin) to C6 and Y1 cells, which utilise different receptors, and which activate adenylate cyclase by different mechanisms, is not inhibited by the bacterial inhibiAs both P-adrenergic and dopaminergic binding were affected, and because the receptors are different for these two somewhat related hormones, our results would predict that either the two receptors are located near each other, and that the inhibitor affects the micro-environment of the two receptors, or, less likely, that the inhibitor had some structural similarity to both ligands. By Scatchard analysis, the bacterial inhibitor appears to affect binding affinity and not receptor nurnber~.~~ ' Although not yet evaluated for the fungal inhibitors, the bacterial inhibitors also block P-agonist (e.g., isoprotereno1)-induced functions (i.e., activation of adenylate cyclase), presumably secondary to their effects on receptor binding8, ' Characterisation of the inhibitors should aid investigations to understand the role of microorganisms in both pathogenic and non-pathogenic infections. Fusarium sp., as well as A.flavus and other filamentous fungi and yeasts, can infect the immunocompromised patient.l6l l7 If /3-adrenergic and dopaminergic responses can be significantly altered during the course of infection and disease, host responses may themselves be compromised. In the lung, for example, several different bacteria (e.g., Haemophilus influenzae, Streptococcus pneumoniae, Bordetella pertussis) have been noted to affect the number of P-receptors.' Patients with respiratory tract infections may experience bronchospasm that can be relieved with the use of P-adrenergic agonists. Should the inhibitors described here be involved in interfering with P-adrenergic responses, further understanding of the nature of the inhibitors and their mechanism of action may lead to improved means to prevent or reverse the inhibition.
4-2
